Abstract
Background It is not known whether steroid therapy affects the serum level of soluble interleukin-2 receptor (sIL-2R) in patients with glomerulonephritis. We therefore examined the relationship between serum level of sIL-2R and indicators of disease activity in patients with immunoglobulin (Ig) A nephropathy, and serum levels of sIL-2R in patients before and after prednisolone therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
